| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581752 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 8 Pages |
Abstract
We have confirmed the role of RISS in unselected nonclinical trial patients and suggest that increased serum lactate dehydrogenase and high-risk cytogenetics are very robust prognosticators when combined with the ISS.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Victor H. Jimenez-Zepeda, Peter Duggan, Paola Neri, Fariborz Rashid-Kolvear, Jason Tay, Nizar J. Bahlis,